TECHNOLOGY solutions provider K-One Technology Bhd said the nasal swabs being manufactured by the company are expected to be marketed in Malaysia, subject to the requisite approval from the local authorities.
In a filing with Bursa Malaysia yesterday, the company said it would obtain approval from the Medical Device Authority under the Ministry of Health for the purpose.
K-One said it is also targeting overseas markets such as the United States, as well European and ASEAN countries, which have high demand for the product, subject to the necessary approvals from the authorities in the respective countries.
On May 6, K-One announced that the company was venturing into the manufacturing of nasal swabs, which are used to collect fluid specimen from the back of the nasal cavity.
K-One had placed orders with a reputable US-based 3D printing technology developer and manufacturer to supply a 3D printer for the purpose of 3D printing the nasal swabs.
“The US-based 3D technology developer and manufacturer, working in collaboration with American healthcare providers, have received the Food and Drug Administration Class 1 Exempt status for their nasal swabs design.
“The former is currently supplying these healthcare providers,” said K-One.
Nasal swabs are typically manufactured using injection molding and flocking, which includes tufts of polyester material attached to the end of a plastic shaft. – May 13, 2020, Bernama
